Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-24-042743
Filing Date
2024-10-29
Accepted
2024-10-28 18:22:28
Documents
104
Period of Report
2024-07-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2235681
2 ex21-1.htm EX-21.1 2899
3 ex31-1.htm EX-31.1 17561
4 ex31-2.htm EX-31.2 17374
5 ex32-1.htm EX-32.1 6834
6 ex32-2.htm EX-32.2 7261
7 ex97-1.htm EX-97.1 51496
8 form10-k_001.jpg GRAPHIC 401394
9 form10-k_002.jpg GRAPHIC 50110
10 form10-k_004.jpg GRAPHIC 278778
11 form10-k_008.jpg GRAPHIC 38250
12 form10-k_009.jpg GRAPHIC 28378
13 form10-k_010.jpg GRAPHIC 39905
14 form10-k_011.jpg GRAPHIC 38104
15 form10-k_012.jpg GRAPHIC 29459
16 form10-k_013.jpg GRAPHIC 7780
17 form10-k_014.jpg GRAPHIC 21411
18 image_001.jpg GRAPHIC 1767
  Complete submission text file 0001493152-24-042743.txt   11725154

Data Files

Seq Description Document Type Size
19 XBRL SCHEMA FILE bctx-20240731.xsd EX-101.SCH 58362
20 XBRL CALCULATION FILE bctx-20240731_cal.xml EX-101.CAL 66274
21 XBRL DEFINITION FILE bctx-20240731_def.xml EX-101.DEF 285692
22 XBRL LABEL FILE bctx-20240731_lab.xml EX-101.LAB 482140
23 XBRL PRESENTATION FILE bctx-20240731_pre.xml EX-101.PRE 412396
107 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1570580
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Filer) CIK: 0001610820 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: 10-K | Act: 34 | File No.: 001-40101 | Film No.: 241402194
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)